AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Dickinson,, MBBS BS DMSc
Peter MacCallum Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
68 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Clayton, Australia
Not, yet, recruiting - Research Site
Macquarie University, Australia
Withdrawn - Research Site
Melbourne, Australia
Recruiting - Research Site
Nedlands, Australia
Not, yet, recruiting - Research Site
Waratah, Australia
Not, yet, recruiting
- Research Site
Antwerp, Belgium
Withdrawn - Research Site
Brussels, Belgium
Not, yet, recruiting - Research Site
Ghent, Belgium
Recruiting - Research Site
Leuven, Belgium
Recruiting - Research Site
Roeselare, Belgium
Suspended - Research Site
Yvoir, Belgium
Recruiting
- Research Site
Porto Alegre, Brazil
Recruiting - Research Site
São Paulo, Brazil
Recruiting
- Research Site
Calgary, Alberta, Canada
Recruiting - Research Site
Victoria, British Columbia, Canada
Not, yet, recruiting - Research Site
Hamilton, Ontario, Canada
Not, yet, recruiting - Research Site
Ottawa, Ontario, Canada
Recruiting
- Research Site
Beijing, China
Recruiting - Research Site
Changchun, China
Recruiting - Research Site
Chengdu, China
Recruiting - Research Site
Chongqing, China
Not, yet, recruiting - Research Site
Fuzhou, China
Not, yet, recruiting - Research Site
Guangzhou, China
Not, yet, recruiting - Research Site
Guangzhou, China
Recruiting - Research Site
Haikou, China
Not, yet, recruiting - Research Site
Hefei, China
Not, yet, recruiting - Research Site
Jinan, China
Recruiting - Research Site
Kunming, China
Not, yet, recruiting - Research Site
Nanchang, China
Not, yet, recruiting - Research Site
Nanning, China
Not, yet, recruiting - Research Site
Nantong, China
Withdrawn - Research Site
Shanghai, China
Recruiting - Research Site
Shanghai, China
Recruiting - Research Site
Wuhan, China
Not, yet, recruiting - Research Site
Xiamen, China
Not, yet, recruiting
- Research Site
Hong Kong, Hong Kong
Recruiting - Research Site
Lai Chi Kok, Hong Kong
Not, yet, recruiting - Research Site
Shatin, Hong Kong
Withdrawn
- Research Site
Akashi, Japan
Not, yet, recruiting - Research Site
Bunkyō City, Japan
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Nov 2025
- Primary completion
- 10 Jun 2030
- Completion
- 28 Jul 2033
- Last update posted
- 18 Jun 2026
- Registered enrollment
- 420
- Registry id
- NCT07215585
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.